This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hospices Civils De Lyon, Universitè Laval, Institut National De La Santé Et De La Recherche Médicale (Inserm). Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 46 
2 out of 304 
1 out of 19 
Years Active: 2022-2026
Title: The Innovative Contributions of Mario Pizzorno
Introduction
Mario Pizzorno is a notable inventor based in Quebec, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compositions aimed at treating influenza. His work reflects a commitment to advancing medical science and improving public health.
Latest Patents
Mario Pizzorno holds a patent for "Antiviral compositions for treating the flu." This invention relates to a pharmaceutical or veterinary composition designed to prevent and/or treat infections caused by influenza viruses. The composition is characterized by the inclusion of at least one compound selected from Etilefrine and Diltiazem, combined with an appropriate pharmaceutical carrier.
Career Highlights
Throughout his career, Mario Pizzorno has worked with esteemed institutions such as Université Claude Bernard Lyon 1 and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mario has collaborated with notable colleagues, including Manuel Rosa-Calatrava and Olivier Terrier. These partnerships have enriched his research and have been instrumental in the development of his innovative antiviral compositions.
Conclusion
Mario Pizzorno's contributions to the field of antiviral treatments exemplify the impact of dedicated inventors in advancing healthcare solutions. His work not only addresses critical health challenges but also
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile